CLDI - Calidi Biotherapeutics, Inc.
0.3607
-0.409 -113.391%
Share volume: 4,164,395
Last Updated: 03-06-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.19%
PREVIOUS CLOSE
CHG
CHG%
$0.77
-0.41
-0.53%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-14-2024 | 08-13-2024 | 11-12-2024 | 05-14-2025 | 11-13-2025 | |
| Assets | ||||||
| Total Assets | 7.405 M | 6.431 M | 6.657 M | 15.064 M | 14.029 M | |
| Current Assets | 1.936 M | 1.625 M | 2.221 M | 11.489 M | 11.028 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 1.143 M | 836.000 K | 1.897 M | 10.561 M | 10.375 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 1.165 M | 1.061 M | 982.000 K | 795.000 K | 849.000 K | |
| Other Assets | 4.304 M | 3.745 M | 3.454 M | 2.780 M | 2.152 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||
| Total Liabilities and shareholders’ equity | 7.405 M | 6.431 M | 6.657 M | 15.064 M | 14.029 M | |
| Total liabilities | 21.978 M | 18.183 M | 16.455 M | 7.765 M | 6.831 M | |
| Total current liabilities | 14.953 M | 13.052 M | 11.579 M | 5.426 M | 5.193 M | |
| Accounts Payable | 3.899 M | 4.547 M | 3.574 M | 1.205 M | 1.148 M | |
| Other liabilities | 3.650 M | 3.206 M | 3.103 M | 2.339 M | 1.638 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 3.375 M | 1.925 M | 1.773 M | 0.000 | 0.000 | |
| Other liabilities | 3.650 M | 3.206 M | 3.103 M | 2.339 M | 1.638 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | -14.573 M | -11.752 M | -10.283 M | 6.941 M | 6.918 M | |
| Common stock | 92.213 M | 100.839 M | 107.409 M | 133.668 M | 144.496 M | |
| Retained earnings | -106.797 M | -112.564 M | -117.618 M | -126.701 M | -137.565 M |